TiumBio Statistics

Total Valuation

TiumBio has a market cap or net worth of KRW 104.90 billion. The enterprise value is 122.62 billion.

Market Cap	104.90B
Enterprise Value	122.62B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

TiumBio has 26.39 million shares outstanding. The number of shares has increased by 5.05% in one year.

Current Share Class	n/a
Shares Outstanding	26.39M
Shares Change (YoY)	+5.05%
Shares Change (QoQ)	+3.68%
Owned by Insiders (%)	32.67%
Owned by Institutions (%)	0.35%
Float	12.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.19
PB Ratio	2.35
P/TBV Ratio	2.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.03
EV / Sales	15.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.94

Financial Position

The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.48.

Current Ratio	2.41
Quick Ratio	2.02
Debt / Equity	0.48
Debt / EBITDA	n/a
Debt / FCF	-1.30
Interest Coverage	-4.20

Financial Efficiency

Return on equity (ROE) is -48.07% and return on invested capital (ROIC) is -14.35%.

Return on Equity (ROE)	-48.07%
Return on Assets (ROA)	-12.30%
Return on Capital (ROIC)	-14.35%
Revenue Per Employee	182.64M
Profits Per Employee	-484.58M
Employee Count	42
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.94% in the last 52 weeks. The beta is 0.78, so TiumBio's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-49.94%
50-Day Moving Average	4,379.50
200-Day Moving Average	5,955.40
Relative Strength Index (RSI)	36.45
Average Volume (20 Days)	42,022

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TiumBio had revenue of KRW 7.67 billion and -20.35 billion in losses. Loss per share was -799.30.

Revenue	7.67B
Gross Profit	7.67B
Operating Income	-18.08B
Pretax Income	-22.39B
Net Income	-20.35B
EBITDA	-14.96B
EBIT	-18.08B
Loss Per Share	-799.30

Full Income Statement

Balance Sheet

The company has 20.88 billion in cash and 26.93 billion in debt, giving a net cash position of -6.05 billion or -229.26 per share.

Cash & Cash Equivalents	20.88B
Total Debt	26.93B
Net Cash	-6.05B
Net Cash Per Share	-229.26
Equity (Book Value)	55.74B
Book Value Per Share	1,693.14
Working Capital	15.68B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.35 billion and capital expenditures -3.31 billion, giving a free cash flow of -20.65 billion.

Operating Cash Flow	-17.35B
Capital Expenditures	-3.31B
Free Cash Flow	-20.65B
FCF Per Share	-782.61

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -235.73% and -265.33%.

Gross Margin	100.00%
Operating Margin	-235.73%
Pretax Margin	-291.90%
Profit Margin	-265.33%
EBITDA Margin	-195.03%
EBIT Margin	-235.73%
FCF Margin	n/a

Dividends & Yields

TiumBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.05%
Shareholder Yield	-5.05%
Earnings Yield	-20.11%
FCF Yield	-19.69%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TiumBio has an Altman Z-Score of -0.02. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.02
Piotroski F-Score	n/a